Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
Yasmin Mesquita, Izabela Pera Calvi, Isabela Reis Marques, Sara Almeida Cruz, Eduardo Messias Hirano Padrão, Pedro E P Carvalho, Caroliny Hellen Silva, Rhanderson Cardoso, Filipe A. Moura, Vladimir Rafalskiy
Topics & Concepts
MedicineInternal medicinePlaceboOdds ratioNauseaWeight lossAdverse effectGastroenterologyType 2 diabetesRandomized controlled trialMeta-analysisCochrane LibraryEndocrinologyDiabetes mellitusObesityPathologyAlternative medicineDiabetes Treatment and ManagementBariatric Surgery and OutcomesPharmacology and Obesity Treatment